FDA nominee Overton parries vaccine questions at Senate hearing

Heidi Overton, the nominee to lead the Food and Drug Administration under the Trump administration, is set to face questions at a Senate hearing this morning at 10:30 a.m. The hearing presents an opportunity to provide insights into her qualifications and potential impact on the agency. If confirmed, Overton, who at 37 would become the youngest FDA commissioner, brings a unique perspective to the role as a preventive medicine physician who served under both Trump administrations.

The FDA has faced challenges over the past 18 months, including politicized decisions and staff changes, and has recently reduced its workforce by nearly 20 percent. Overton's appointment has raised concerns among lawmakers and industry representatives about her limited managerial experience and her commitment to policies influenced by health secretary Robert F. Kennedy Jr., particularly her involvement in efforts to modify the childhood vaccine schedule.

Senate Committee on Health, Education, Labor and Pensions chairman Sen. Bill Cassidy (R-La.) has expressed particular skepticism regarding Overton's suitability for the position.